HSBC upgrades Visual Photonics Epitaxy stock to Buy on strong optical/AI demand

HSBC upgraded Visual Photonics Epitaxy Co Ltd (TPE:2455) to Buy from Hold, raising its price target to NT$193.00 from NT$99.00, driven by expectations of strong optical and AI demand in 2026. Despite an 18% cut to its 2025 EPS estimate due to near-term product mix and foreign exchange impacts, the firm increased its 2026 EPS forecast by 14% and raised the target P/E multiple to 33x, reflecting a projected 53% earnings compound annual growth rate for 2025-2027. The new price target implies approximately 31% upside potential, with HSBC noting that the anticipated Q2 2025 sales decline is largely priced into the stock.

Analysis

HSBC has upgraded Visual Photonics Epitaxy Co Ltd (TPE:2455) to Buy from Hold, substantially increasing its price target to NT$193.00 from NT$99.00, implying approximately 31% upside. The core of this thesis is a forward-looking view centered on strong demand from the optical and artificial intelligence sectors expected in 2026. This long-term optimism intentionally looks past significant near-term headwinds, as HSBC simultaneously cut its 2025 EPS estimate by 18% due to unfavorable product mix and foreign exchange pressures. This creates a non-consensus outlook, with HSBC's 2025 EPS forecast now 12% below the market average, while its 2026 EPS forecast is 13% above. The valuation has been significantly re-rated, with the target price-to-earnings multiple expanding to 33x from 25x. This is justified by a projected 53% earnings compound annual growth rate for 2025-2027, which follows a notable 12% year-over-year earnings decline anticipated for 2025. The bank's position is that the market has already priced in the expected Q2 2025 sales weakness, creating an opportunity for investors to position for the subsequent recovery.

Key Decisions for Investors

• Investors should consider this a long-term opportunity, as the thesis is contingent on a significant earnings inflection point in 2026 driven by AI and optical demand, not on near-term performance.
• Be prepared for potential near-term volatility and weak fundamentals, given HSBC's forecast of an 18% cut to 2025 EPS and a 12% year-over-year earnings decline before the projected recovery begins.
• The investment case heavily relies on a valuation re-rating to a 33x P/E multiple, so investors must have conviction in the firm's ability to achieve the projected 53% earnings CAGR from 2025-2027 to justify this premium.